Defining Optimal Immunotherapies for Type 1 Diabetes
Defining Optimal Immunotherapies for Type 1 Diabetes
Subtitle: Novartis Foundation Symposium
by: Novartis Foundation
Paperback: 224 pages
Publisher: John Wiley & Sons, Ltd.( October 24, 2008 )
ISBN-10: 0470723254